Literature DB >> 15221336

Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas.

A Gutenberg1, W Brück, M Buchfelder, H C Ludwig.   

Abstract

The progression of malignancy from astrocytomas to glioblastomas remains clinically as well as histopathologically unpredictable. The focal adhesion kinase (FAK) and the proline-rich tyrosine kinase (Pyk2) show a high expression in glioma cell lines and have an influence on increased cell proliferation and migration of glioma cells in vitro and in vivo. The aim of this study was to correlate the coexpression of FAK and Pyk2 to the WHO grade of malignancy in human astrocytomas. Immunohistochemical staining scores of FAK and Pyk2 were analyzed in 331 astrocytomas and correlated to each other and to the WHO grade. Significant coexpression of FAK and Pyk2 in astrocytomas was demonstrated. Pyk2 expression occurred much more frequently and with higher expression scores within the different WHO grades. Beyond this, a significant correlation between the WHO grade of malignancy of astrocytomas and the expression of FAK, as well as of Pyk2, was detected. This connection and the roles of these two tyrosine kinases in the progression of tumors should be confirmed by further studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221336     DOI: 10.1007/s00401-004-0886-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.

Authors:  Christopher A Lipinski; Nhan L Tran; Emmanuel Menashi; Carole Rohl; Jean Kloss; R Curtis Bay; Michael E Berens; Joseph C Loftus
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

2.  TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling.

Authors:  Vincent M Paulino; Zhongbo Yang; Jean Kloss; Matthew J Ennis; Brock A Armstrong; Joseph C Loftus; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2010-09-29       Impact factor: 5.852

Review 3.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

4.  The dual kinase complex FAK-Src as a promising therapeutic target in cancer.

Authors:  Victoria Bolós; Joan Manuel Gasent; Sara López-Tarruella; Enrique Grande
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

5.  TWIST1 promotes invasion through mesenchymal change in human glioblastoma.

Authors:  Svetlana A Mikheeva; Andrei M Mikheev; Audrey Petit; Richard Beyer; Robert G Oxford; Leila Khorasani; John-Patrick Maxwell; Carlotta A Glackin; Hiroaki Wakimoto; Inés González-Herrero; Isidro Sánchez-García; John R Silber; Philip J Horner; Robert C Rostomily
Journal:  Mol Cancer       Date:  2010-07-20       Impact factor: 27.401

6.  Mesenchymal migration as a therapeutic target in glioblastoma.

Authors:  Jessie Zhong; Andre Paul; Stewart J Kellie; Geraldine M O'Neill
Journal:  J Oncol       Date:  2010-06-21       Impact factor: 4.375

7.  Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.

Authors:  Emy Behmoaram; Krikor Bijian; Su Jie; Yingjie Xu; Andrew Darnel; Tarek A Bismar; Moulay A Alaoui-Jamali
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

8.  The Pyk2 FERM domain as a target to inhibit glioma migration.

Authors:  Joseph C Loftus; Zhongbo Yang; Nhan L Tran; Jean Kloss; Carole Viso; Michael E Berens; Christopher A Lipinski
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

9.  Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts.

Authors:  Christopher A Lipinski; Nhan L Tran; Carole Viso; Jean Kloss; Zhongbo Yang; Michael E Berens; Joseph C Loftus
Journal:  J Neurooncol       Date:  2008-07-22       Impact factor: 4.130

Review 10.  Systematic review of protein biomarkers of invasive behavior in glioblastoma.

Authors:  Eli T Sayegh; Gurvinder Kaur; Orin Bloch; Andrew T Parsa
Journal:  Mol Neurobiol       Date:  2013-11-24       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.